These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 11753827
1. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy. Berenguer J, González J, Pulido F, Padilla B, Casado JL, Rubio R, Arribas JR, Madrid Group for the Study of Discontinuation of Secondary Prophylaxis in Patients with CMV Retinitis. Clin Infect Dis; 2002 Feb 01; 34(3):394-7. PubMed ID: 11753827 [Abstract] [Full Text] [Related]
5. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. Jacobson MA, Schrier R, McCune JM, Torriani FJ, Holland GN, O'Donnell JJ, Freeman WR, Bredt BM. J Infect Dis; 2001 May 01; 183(9):1399-404. PubMed ID: 11294673 [Abstract] [Full Text] [Related]
6. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM. J Infect Dis; 2001 Apr 15; 183(8):1285-9. PubMed ID: 11262214 [Abstract] [Full Text] [Related]
7. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy. Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA, Studies of Ocular Complications of AIDS Researh Group. Ophthalmology; 2003 May 15; 110(5):987-95. PubMed ID: 12750102 [Abstract] [Full Text] [Related]
9. Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients. Lilleri D, Piccinini G, Genini E, Comolli G, Chiesa A, Tordato F, Sotgiu G, Parisi A, Baldanti F, Revello MG, Gerna G. J Clin Virol; 2004 Apr 15; 29(4):297-307. PubMed ID: 15018859 [Abstract] [Full Text] [Related]
10. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype. Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA, Studies of Ocular Complications of AIDS Research Group. J Infect Dis; 2006 Dec 01; 194(11):1537-46. PubMed ID: 17083038 [Abstract] [Full Text] [Related]
11. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK. Am J Ophthalmol; 2005 Jun 01; 139(6):1028-34. PubMed ID: 15953432 [Abstract] [Full Text] [Related]
17. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese. Lin YC, Yang CH, Lin CP, Yang CM, Chen MS, Chen MY, Sheng WH, Hung CC, Chang SC. Ocul Immunol Inflamm; 2008 Dec 01; 16(3):83-7. PubMed ID: 18569793 [Abstract] [Full Text] [Related]
18. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Kedhar SR, Jabs DA. Herpes; 2007 Dec 01; 14(3):66-71. PubMed ID: 18371289 [Abstract] [Full Text] [Related]
19. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL, Studies of Ocular Complications of AIDS Research Group. Ophthalmology; 2006 Aug 01; 113(8):1432-40. PubMed ID: 16766032 [Abstract] [Full Text] [Related]